Done sou Salè H1B

Akèy › Anplwayè › Vertex Pharmaceuticals Incorporated › Stem Cell Senior Research Associate

Stem Cell Senior Research Associate nan Vertex Pharmaceuticals Incorporated: Salè H-1B

7 aplikasyon kondisyon travay pou tit travay Stem Cell Senior Research Associate nan Vertex Pharmaceuticals Incorporated. Salè baz medyàn ofri $85,842; mwatye mitan $74,822–$88,608.

Demann (LCA)7
Salè medyan ofri$85,842
Mwatye salè yo$74,822–$88,608
10yèm–90yèm pousantaj$73,721–$91,616

Pa ane fiskal

Ane fiskalLCASalè medyan
FY20244$74,822
FY20252$85,842
FY20261$91,978

Aplikasyon

Salè bazKoteSoumètDat kòmansmanEstati
$91,978–$112,200
Nivo II
Boston, MAApr 15, 2026Oct 1, 2026Certifye
$85,842–$110,337
Nivo II
Boston, MAApr 21, 2025Oct 1, 2025Certifye
$85,842–$106,802
Nivo II
Boston, MAMar 13, 2025Mar 31, 2025Certifye
$74,418–$100,683
Nivo I
Boston, MAAug 15, 2024Oct 1, 2024Certifye
$75,225–$101,775
Nivo I
Boston, MAJul 22, 2024Aug 26, 2024Certifye
$72,675–$98,325
Nivo I
Boston, MAMay 14, 2024Oct 1, 2024Certifye
$91,374–$99,981
Nivo I
Boston, MAApr 16, 2024Oct 1, 2024Certifye

Lòt travay nan Vertex Pharmaceuticals Incorporated

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).